US 2018/0250372 A1Published application

Compositions for treating an arthritic condition

AssigneesTxcell, Universite De Montpellier, Centre Hospitalier Regional Universitaire De Montpellier

InventorsArnaud Foussat, Valerie Brun, Helene Asnagli, Nathalie Belmonte, Christian Jorgensen

Life of this patent

Estimating the term…

Abstract

Methods for treating an arthritic condition in a subject by administering to the subject at least one human Tr1 cell population directed to a joint-associated antigen.

Claims18

Dependent claims

A method for treating an arthritic condition in a subject, comprising administering to the subject at least one human Tr1 cell population directed against a joint-associated antigen.

Dependencies are inferred from the claim text.

Facts

Application: 15/980,337Filed 15 May 2018
Priority: EP 08305133.428 Apr 2008
Published: 6 Sep 2018
Term ends: Not estimatedThe source records don’t support an estimate.

Classification15 codes

A61K 39/0008
Vertebrate antigens: antigens related to auto-immune diseases; Preparations to induce self-tolerance
A61K 40/11
Characterised by the cell type used: t-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer…
A61K 40/22
Characterised by the effect or the function of the cells: immunosuppressive or immunotolerising
A61K 40/416
Vertebrate antigens: antigens related to auto-immune diseases; Preparations to induce self-tolerance

Family

Application61/048,309Us provisional application · filed 28 Apr 2008
Application12/989,857Division · filed 27 Oct 2010
Application15/980,337Division
US 2011/0038844 A1Published application
US 2018/0250372 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results